Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

King Tigan 300 Mg Promos Planned After FDA Trimethobenzamide Notice

Related Content

King Tigan Approval Expected In Six Months; Bioequivalence Data Submitted

Oct 08 2001

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window